These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 25920320)

  • 21. Impact of Antibiotic-Resistant Bacteria on Immune Activation and Clostridioides difficile Infection in the Mouse Intestine.
    Keith JW; Dong Q; Sorbara MT; Becattini S; Sia JK; Gjonbalaj M; Seok R; Leiner IM; Littmann ER; Pamer EG
    Infect Immun; 2020 Mar; 88(4):. PubMed ID: 31907198
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clostridium difficile infection.
    Kelly CP; LaMont JT
    Annu Rev Med; 1998; 49():375-90. PubMed ID: 9509270
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differences of the Fecal Microflora With Clostridium difficile Therapies.
    Louie TJ; Byrne B; Emery J; Ward L; Krulicki W; Nguyen D; Wu K; Cannon K
    Clin Infect Dis; 2015 May; 60 Suppl 2():S91-7. PubMed ID: 25922407
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity.
    Zar FA; Bakkanagari SR; Moorthi KM; Davis MB
    Clin Infect Dis; 2007 Aug; 45(3):302-7. PubMed ID: 17599306
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of treatment outcomes with vancomycin alone versus combination therapy in severe Clostridium difficile infection.
    Bass SN; Bauer SR; Neuner EA; Lam SW
    J Hosp Infect; 2013 Sep; 85(1):22-7. PubMed ID: 23876778
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnosis and management of Clostridium difficile infection.
    Dupont HL
    Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1216-23; quiz e73. PubMed ID: 23542332
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is there a relationship between vancomycin-resistant enterococcal infection and Clostridium difficile infection?
    Gerding DN
    Clin Infect Dis; 1997 Sep; 25 Suppl 2():S206-10. PubMed ID: 9310680
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea.
    Tart SB
    J Pharm Pract; 2013 Oct; 26(5):488-90. PubMed ID: 23940121
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clostridium difficile infection in the elderly.
    Keller JM; Surawicz CM
    Clin Geriatr Med; 2014 Feb; 30(1):79-93. PubMed ID: 24267604
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidemiology, diagnosis and treatment of Clostridium difficile infection.
    Bassetti M; Villa G; Pecori D; Arzese A; Wilcox M
    Expert Rev Anti Infect Ther; 2012 Dec; 10(12):1405-23. PubMed ID: 23253319
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro susceptibility of genotypically distinct and clonal Clostridium difficile strains to oritavancin.
    O'Connor R; Baines SD; Freeman J; Wilcox MH
    J Antimicrob Chemother; 2008 Oct; 62(4):762-5. PubMed ID: 18606787
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vancomycin-resistant Enterococcus co-colonization rates with methicillin-resistant Staphylococcus aureus and Clostridium difficile in critically ill veterans.
    McKinley L; Becerra B; Moriarty H; Short TH; Hagle M; Reymann A; Valentine S; Duster M; Warrack S; Safdar N
    Am J Infect Control; 2016 Sep; 44(9):1047-9. PubMed ID: 27067517
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vancomycin vs Metronidazole for Clostridium difficile infection: focus on recurrence and mortality.
    Wu MA; Leidi F;
    Intern Emerg Med; 2017 Sep; 12(6):871-872. PubMed ID: 28681270
    [No Abstract]   [Full Text] [Related]  

  • 34. A modified R-type bacteriocin specifically targeting Clostridium difficile prevents colonization of mice without affecting gut microbiota diversity.
    Gebhart D; Lok S; Clare S; Tomas M; Stares M; Scholl D; Donskey CJ; Lawley TD; Govoni GR
    mBio; 2015 Mar; 6(2):. PubMed ID: 25805733
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Best strategies in recurrent or persistent Clostridium difficile infection.
    Cocanour CS
    Surg Infect (Larchmt); 2011 Jun; 12(3):235-9. PubMed ID: 21767157
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibiotic-Induced Alterations of the Murine Gut Microbiota and Subsequent Effects on Colonization Resistance against Clostridium difficile.
    Schubert AM; Sinani H; Schloss PD
    mBio; 2015 Jul; 6(4):e00974. PubMed ID: 26173701
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clostridium difficile infection: clinical spectrum and approach to management.
    Vaishnavi C
    Indian J Gastroenterol; 2011 Dec; 30(6):245-54. PubMed ID: 22183580
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Short- and long-term effects of oral vancomycin on the human intestinal microbiota.
    Isaac S; Scher JU; Djukovic A; Jiménez N; Littman DR; Abramson SB; Pamer EG; Ubeda C
    J Antimicrob Chemother; 2017 Jan; 72(1):128-136. PubMed ID: 27707993
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Successful treatment of simulated Clostridium difficile infection in a human gut model by fidaxomicin first line and after vancomycin or metronidazole failure.
    Chilton CH; Crowther GS; Freeman J; Todhunter SL; Nicholson S; Longshaw CM; Wilcox MH
    J Antimicrob Chemother; 2014 Feb; 69(2):451-62. PubMed ID: 24003182
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clostridium difficile infection in older adults: a review and update on its management.
    Kee VR
    Am J Geriatr Pharmacother; 2012 Feb; 10(1):14-24. PubMed ID: 22260856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.